{"schema_version":"secwatch.filing_event.v1","accession":"0001096906-24-000199","form_type":"8-K","ticker":"AXIM","cik":"0001514946","company_name":"AXIM BIOTECHNOLOGIES, INC.","filed_at":"2024-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.449531+00:00","generated_at":"2026-06-06T03:22:01.715303+00:00","sec_items":["1.01","3.02"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"AXIM Biotechnologies settles IMS litigation; to issue 20M restricted shares plus cash and royalties","bullets":["Settlement with Innovative Medical Supplies resolves two lawsuits; no admission of wrongdoing.","Cash payment of $100,000 payable over 24 months.","Royalty of $0.35 per dry eye test cassette sold, capped at $475,000 total.","Issues 20M restricted shares; 12-month lock-up, then drip-out limit of 1% of outstanding per 90 days.","Shares issued under Section 4(a)(2) of Securities Act; unregistered sale."],"urls":{"canonical":"https://secwatch.observer/filing/0001096906-24-000199","json":"https://secwatch.observer/filing/0001096906-24-000199.json","markdown":"https://secwatch.observer/filing/0001096906-24-000199.md","text":"https://secwatch.observer/filing/0001096906-24-000199.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514946/000109690624000199/0001096906-24-000199-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514946/000109690624000199/axim-20240207.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T03:22:01.715303+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a485aaff31bbee300c6ce96398ef3f75f4b597cb","claim":"AXIM BIOTECHNOLOGIES, INC. entered into Settlement Agreement with Innovative Medical Supplies, LLC (effective 2024-02-07).","evidence_excerpt":"Effective February 7, 2024, the Company entered into a confidential Global Settlement Agreement and Mutual Release (the “Settlement Agreement”) to resolve the IMS Action as well as a second related action involving many of the same parties.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690624000199/0001096906-24-000199-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"settlement"},{"label":"Counterparty","value":"Innovative Medical Supplies, LLC"},{"label":"Effective","value":"2024-02-07"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}